Treatment of chronic post-radiation cystitis with trans-urethral amniotic bladder therapy appears durable at 9 months: A clinical study.

Jonathan LutchkaJack VercnockeEmily FisherCodrut RadoiuJulian JeberaeelSteven LucasNivedita Dhar

Published in: Urologia (2024)

Our data suggest that a significant number of CRC patients may have durable benefit after ABT. Despite this, some of them can show symptoms rebound at 24 weeks.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
spinal cord injury
prognostic factors
electronic health record
stem cells
clinical trial
machine learning
radiation therapy
mesenchymal stem cells
data analysis
gestational age
chemotherapy induced